Whistleblower Sarah Behnke's lawsuit leads to a $290 million judgment against CVS Caremark for overcharging Medicare on ...

Chief Judge Mitchell Goldberg tripled to $285 million the damages he had ordered CVS Caremark to pay in June, citing the federal False Claims Act.

A federal judge has ordered CVS Caremark to pay nearly $290 million in damages after determining the pharmacy benefit manager overbilled Medicare for prescription drugs, according to court documents ...

A federal judge has ordered CVS Caremark to pay almost $290 million in damages and penalties after a whistleblower proved the ...

Notably, the case came from a whistleblower lawsuit filed by Sarah Behnke, a former Medicare Part D actuary at Aetna, who ...

A Pennsylvania judge has ordered CVS to pay $289 million in damages as part of a long-running whistleblower case. | A Pennsylvania judge has ordered CVS to pay $289 million in damages as part of a ...

CVS Caremark, the pharmacy benefit management division of Woonsocket, R.I.-based CVS Health, stands accused of improperly reporting Medicare generic drug prices to CMS, according to a STAT report.

CVS risks losing customers and revenue if it splits up its vertically integrated business segments, which includes health insurer Aetna and the major pharmacy benefits manager Caremark.

CVS acquired Aetna in 2018. In October, CVS replaced Karen Lynch, the former chief executive officer, with David Joyner, who had been the president of the CVS Caremark pharmacy benefit manager ...

Lynch, who held the top spot at CVS since 2021 and previously led insurer Aetna, stepped down “in agreement with the company’s Board of Directors,” according to a release.

The whistleblower, Sarah Behnke, is a former head actuary for Medicare Part D at Aetna, which CVS bought in 2018. Actual damages due to Caremark’s scheme reached $95 million.